KM Pharmaceutical Expands Global Skincare and Oral Care OEM/ODM Platform
KOSDAQ-listed KM Pharmaceutical (code 225430) is expanding its global skincare and oral care OEM/ODM platform centered on an advanced functional product portfolio, reflecting Korean beauty manufacturers' continued push into international contract manufacturing markets.
Korean cosmetics contract manufacturer KM Pharmaceutical (KOSDAQ: 225430) has announced the expansion of its global skincare and oral care OEM/ODM platform, with a core strategy of leveraging an advanced functional product portfolio to strengthen international competitiveness. The company covers both skincare and oral care categories, using functional formulations as a key differentiator for global brand clients.
From a positioning perspective, KM Pharmaceutical presents itself as a comprehensive contract manufacturing solutions provider within the K-Beauty value chain rather than a single-category manufacturer. Running skincare and oral care in parallel helps diversify category risk across different market cycles and offers brand clients one-stop development options.
For B2B buyers and brand owners, Korean contract manufacturers' technical capabilities in functional product development merit attention, particularly in formulation innovation and regulatory compliance, making them viable candidates for supply chain evaluation.
Source:Yahoo Finance
Note: compiled and rewritten by BIOSPHERE editors from public reporting; illustration AI-generated. See the source for full details.